OUT OF THE BOX

Finnish mobile device for detecting arrhythmia soon available for consumers

The VTT spin-off, VitalSignum, is making a small mobile device – which detects arrhythmia by measuring the patient’s ECG – available to consumers. The first production batch is being completed and will be retailed to consumers in early October.

The device has been tested, with good results, on heart patients for three years at the University Hospital of Turku and now also within the Hospital District of Helsinki and Uusimaa. Top athletes suffering from heart problems and many other private individuals have also tested the innovation.

Effortlessly portable

This highly portable device precisely measures the patient’s ECG and heart rate variability (HRV). Medical device approval will be sought next, after which the device will be suitable for preoperative and postoperative monitoring of cardiac patients at home, since the data is automatically transferred from a cell phone to nursing staff via a cloud service.

“Arrhythmia tends to remain undiagnosed, if no symptoms are detected during Holter monitoring of heart activity. The compact new device, which can easily be concealed under clothes, will also provide a solution to this, by sending data on arrhythmia directly to a mobile phone,” says Timo Varpula CTO of VitalSignum, who developed the technology while at VTT Technical Research Centre of Finland. The journey from research to consumer product has been short – the company began operating only six months ago.

Known as the Beat2Phone, the device comprises software which runs on Android phones and a sensor which fits onto a flexible chest belt. These measure ECG signals at an extremely high resolution, identify individual heart beats and confirm the interval between consecutive beats. The device also includes position and activity sensors.

“Advance demand for the device has exceeded our expectations,” says CEO Veli-Heikki Saari.

The number of potential users will grow as the population ages. About 5% of the population suffers from cardiac arrhythmia, which is detected in around 12% of people over the age of 60. The number of people engaged in endurance sports is also rising.

Read more: https://www.beat2phone.com

 

Liat

Recent Posts

Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein – the Largest Known to Be Simulated with Quantum Computers

Milestone simulation of biologically meaningful molecules expands quantum-centric supercomputing’s role as a scientific tool Scientists…

3 days ago

Never lose the signal: the Israeli company redefining military communications

Commcrete develops compact satellite communication devices that maintain secure connectivity during combat, rescue, and electronic…

3 days ago

Yaron Elad and Elik Etzion Launch AlphaDrive, a $100 Million Fund Focusing on Cyber and AI Investments

Leumi Partners has joined the fund as an anchor investor. The fund has already invested…

5 days ago

60W DOE Level VII ready IP42-sealed wall-mount adapters for medical, home healthcare, and industrial applications

XP Power introduces the AMF60 series of 60W wall-mount AC-DC power supplies for medical, home…

2 weeks ago

ROHM launches an Ultra-Compact Wireless Power Chipset for Wearables

ROHM has developed a wireless power supply IC chipset consisting of the receiver - ML7670 -…

2 weeks ago

Microchip Expands its Family of Post-Quantum Ready Root of Trust Controllers for Next Generation Systems

Platform Root of Trust and secure boot controllers help system architects prepare for emerging mandates…

2 weeks ago